Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Autors principals: | , , , , , , , , , |
---|---|
Format: | Conference item |
Publicat: |
Oxford University Press
2017
|
Sumari: |
---|